Clinical Report: Evaluation of Valved Holding Chambers for Pediatric Asthma Management

Overview

This study evaluates the performance of three valved holding chambers (VHCs) for delivering inhaled medications in pediatric asthma management. It specifically assesses fine particle delivery, total delivered dose, and throat deposition of fluticasone mono-inhaler, fluticasone/salmeterol combination inhaler, and ciclesonide under simulated pediatric breathing conditions.

Background

Asthma is a significant cause of morbidity in children, necessitating effective management strategies. The use of pressurized metered-dose inhalers (pMDIs) with VHCs is recommended for delivering inhaled corticosteroids in young children. However, variations in device performance can impact drug delivery, particularly in pediatric patients with variable respiratory patterns.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

• VHCs differ in design, which can affect drug delivery efficiency.
• Optimal lung deposition for pediatric patients may require particles in the 1-3 μm range.
• Fluticasone is recommended as the primary ICS for children requiring therapy via pMDI.
• Combination therapy with ICS and LABA remains off-label for children under five due to insufficient data.
• Previous studies indicate significant variability in drug delivery among different VHCs under simulated pediatric conditions.

Clinical Implications

Healthcare providers should consider the specific VHC model used when prescribing inhaled medications for pediatric asthma management. Understanding the differences in drug delivery performance among VHCs can guide clinicians in optimizing treatment for young patients.

Conclusion

The evaluation of VHCs is crucial for ensuring effective asthma management in pediatric patients. Further research is needed to fully understand the implications of VHC design on drug delivery.

Related Resources & Content

1. JAMA Pediatrics, 2026 -- Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial
2. Frontiers in Pediatrics, 2026 -- An observational study of quick-relief inhaler storage and use among children with asthma in home, school, and community
3. Intensive Care Medicine -- Guidelines for Mechanical Ventilation in Critically Ill Pediatric Patients from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)
4. GINA Summary Guide 2026
5. Intensive Care Medicine — Review of Key Developments in Intensive Care Medicine for 2009: Focus on Mechanical Ventilation, Acute Lung Injury, Respiratory Distress Syndrome, Pediatric Considerations, Ethical Issues, and Additional Topics
6. GINA Main Report 2023
7. https://ginasthma.org/wp-content/uploads/2026/07/GINA-Summary-Guide-2026-WEB-WMS.pdf
8. Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial | Trials | JAMA Pediatrics | JAMA Network
9. Comparative Efficacy of Two Inhalational Techniques when Using a Pressurized Meter Dose Inhaler with Valved Holding Chamber in Children with Asthma: A Randomized Controlled Trial - Rashmi Ranjan Das, Amit Kumar Satapathy, Manoj Kumar Panigrahi, 2026
10. In Vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy - Tampereen yliopiston tutkimusportaali
11. Inhaled corticosteroid delivery is markedly affected by breathing pattern and valved holding chamber model | European Respiratory Society
12. Aerosol delivery using pediatric valved holding chamber face masks under real-life application pressure | European Respiratory Society
13. UK Inhaler Group (UKIG) consensus guide on spacer devices | Primary Care Respiratory Society